Abstract
Aims:
The study aimed to determine if the Kindlin-2/Otub1/Slc7a11 cascade could improve cardiac ischemia reperfusion injury by inhibiting ferroptosis.
Results:
The cardiac tissues of ischemia — reperfusion (I/R) mice, ischemic cardiomyopathy (ICM) patients, and cardiomyocytes underwent hypoxia/reoxygenation stimulation, and the Kindlin-2 levels decreased. Cardiomyocyte-specific Kindlin-2 overexpression alleviated I/R injury by inhibiting cardiomyocyte ferroptosis in vivo while cardiomyocyte-specific low expression of Kindlin-2 impaired cardiac functions, and this was accompanied by cardiomyocyte ferroptosis and reversed by Fer-1. In addition, in vitro experiments verified that Kindlin-2 prevented ferroptosis in cardiomyocytes treated with hypoxia/reoxygenation. An endogenous Kindlin-2 deficiency in cardiomyocytes was subsequently identified to spontaneously induce ferroptosis without exogenous stimulation, which is also prevented by Fer-1. Mechanistically, Kindlin-2 accelerated the interaction between Otub1 and Slc7a11. Consequently, deubiquitinated Slc7a11 contributed to the activation of glutathione (GSH) and Gpx4 to exert the anti-ferroptosis effect. Slc7a11/GSH/Gpx4 cascades strengthened by Kindlin-2 were abolished by Otub1 knock down. Moreover, Otub1 rescued cardiomyocyte ferroptosis and cardiac injury due to the Kindlin-2 deficiency.
Innovation:
Kindlin-2 accelerated the interaction between Otub1 and Slc7a11. Therefore, Slc7a11/GSH/GPX4 cascades were reinforced to improve the deteriorated tissues of I/R hearts by ameliorating ferroptosis.
Conclusions:
Our research revealed that the Kindlin-2/Otub1/Slc7a11 cascade improved cardiac I/R injury by inhibiting ferroptosis; hence, it may be a potential therapeutic target for ICM. Antioxid. Redox Signal. 43, 727–744.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
